Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction

View through CrossRef
Evaluation of dosing regimens for critically ill patients requires pharmacokinetic data in this population. This prospective observational study aimed to describe the population pharmacokinetics of unbound ceftolozane and tazobactam in critically ill patients without renal impairment and to assess the adequacy of recommended dosing regimens for treatment of systemic infections. Patients received 1.5 or 3.0 g ceftolozane-tazobactam according to clinician recommendation.
Title: Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction
Description:
Evaluation of dosing regimens for critically ill patients requires pharmacokinetic data in this population.
This prospective observational study aimed to describe the population pharmacokinetics of unbound ceftolozane and tazobactam in critically ill patients without renal impairment and to assess the adequacy of recommended dosing regimens for treatment of systemic infections.
Patients received 1.
5 or 3.
0 g ceftolozane-tazobactam according to clinician recommendation.

Related Results

Challenging Management of Postoperative Empyema: A Case Report with Literature Review
Challenging Management of Postoperative Empyema: A Case Report with Literature Review
Abstract Introduction: Pleural empyema is the collection of pus within the pleural cavity, typically arising as a complication of pneumonia, chest trauma, thoracic surgery, or bact...
Cerebrospinal Fluid Penetration of Ceftolozane-Tazobactam in Critically Ill Patients with an Indwelling External Ventricular Drain
Cerebrospinal Fluid Penetration of Ceftolozane-Tazobactam in Critically Ill Patients with an Indwelling External Ventricular Drain
The aim of this study was to describe the pharmacokinetics of ceftolozane-tazobactam in plasma and cerebrospinal fluid (CSF) of infected critically ill patients. In a prospective o...
MO298: Predictors of Renal Function Recovery in Critically ill Patients With Acute Kidney Injury
MO298: Predictors of Renal Function Recovery in Critically ill Patients With Acute Kidney Injury
Abstract BACKGROUND AND AIMS Acute kidney injury (AKI) is a frequent and serious complication in critically ill patients admitte...
Perioperative Acute Renal Injury: Revisiting Pathophysiology
Perioperative Acute Renal Injury: Revisiting Pathophysiology
Background Acute renal dysfunction and subsequent acute renal failure after cardiac surgery are associated with high mortality and morbidity. Early therapeutic or preve...
Determinación de la actividad de ceftolozane/tazobactam en cepas de Pseudomonas aeruginosa
Determinación de la actividad de ceftolozane/tazobactam en cepas de Pseudomonas aeruginosa
Introducción: El aumento constante de infecciones producidas por Pseudomonas aeruginosa se considera una de las principales causas asociadas a la reducción de alternativas terapéut...
Tazobactam selects for multidrug resistance
Tazobactam selects for multidrug resistance
Abstract Piperacillin-Tazobactam is a β-lactam/β-lactamase inhibitor combination that is amongst the most prescribed antimicrobials in hospital medicine. Piperacillin is ...
Tazobactam selects for multidrug resistance
Tazobactam selects for multidrug resistance
Abstract Piperacillin-Tazobactam is a β-lactam/β-lactamase inhibitor combination which is amongst the most prescribed antimicrobials in hospital ...

Back to Top